Phathom Pharmaceuticals SG&A Expense (Annual) Trends

Phathom Pharmaceuticals Inc (PHAT)

17.25 -0.90 (-4.96%) USD | NASDAQ | Oct 04, 16:00

17.26 0.00 (0.00%) After-Hours: 20:00

SG&A Expense (Annual) Chart

Historical SG&A Expense (Annual) Data

View and export this data back to 2018. Upgrade now.

Date	Value
December 31, 2023	117.93M
December 31, 2022	101.00M
December 31, 2021	62.74M

Date	Value
December 31, 2020	27.52M
December 31, 2019	6.944M
December 31, 2018	1.205M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Annual) Range, Past 5 Years

6.944M

Minimum

2019

117.93M

Maximum

2023

63.23M

Average

62.74M

Median

2021

SG&A Expense (Annual) Benchmarks